SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter
- 18 April 2006
- journal article
- review article
- Published by Elsevier BV in Life Sciences
- Vol. 78 (21), 2419-2425
- https://doi.org/10.1016/j.lfs.2005.10.028
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene familyBiochemical Journal, 2005
- Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitorCancer Biology & Therapy, 2005
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Biological functions of SLC5A8, a candidate tumour suppressorBiochemical Society Transactions, 2005
- The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesisOncogene, 2004
- Synergistic Induction of Oxidative Injury and Apoptosis in Human Multiple Myeloma Cells by the Proteasome Inhibitor Bortezomib and Histone Deacetylase InhibitorsClinical Cancer Research, 2004
- Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibitionBiochemical and Biophysical Research Communications, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrateCell Death & Differentiation, 1998